These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3052614)

  • 1. Growth factors: soluble mediators of wound repair and ocular fibrosis.
    Hjelmeland LM; Harvey AK
    Birth Defects Orig Artic Ser; 1988; 24(1):87-102. PubMed ID: 3052614
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration.
    Wiedemann P
    Surv Ophthalmol; 1992; 36(5):373-84. PubMed ID: 1566240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of wound-related complications in pars plana vitrectomy.
    Kreiger AE
    Trans Am Ophthalmol Soc; 1994; 92():307-20; discussion 320-4. PubMed ID: 7886870
    [No Abstract]   [Full Text] [Related]  

  • 4. [Intraocular fibrosis after perforating injury of the posterior segment. Experimental study].
    Kantelip B; Bacin F
    J Fr Ophtalmol; 1985; 8(3):245-53. PubMed ID: 4056316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth factors as regulators of wound repair.
    Grotendorst GR
    Int J Tissue React; 1988; 10(6):337-44. PubMed ID: 3076586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytologic aspects of the cellular proliferation of the posterior segment].
    Monteiro-Grillo M; da Silva JR; de Vasconcelos AI; Parreira F
    Ophtalmologie; 1988; 2(1):23-4. PubMed ID: 3247131
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotaxis of rat retinal glia to growth factors found in repairing wounds.
    Harvey AK; Roberge F; Hjelmeland LM
    Invest Ophthalmol Vis Sci; 1987 Jul; 28(7):1092-9. PubMed ID: 3496317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Possibilities of eye immobilization in vitreoretinal diseases. Comparative analysis of residual movement].
    Koerner R; Hänny P
    Fortschr Ophthalmol; 1982; 79(4):331-5. PubMed ID: 7185706
    [No Abstract]   [Full Text] [Related]  

  • 9. Possible metabolic mechanisms modulating blood vessel development in the inner eye and their significance for vascular pathology in the definitive eye.
    Michaelson IC; Benezra D; Berson D
    Metab Pediatr Syst Ophthalmol; 1982; 6(1):1-10. PubMed ID: 6182443
    [No Abstract]   [Full Text] [Related]  

  • 10. Proliferative vitreoretinopathy (PVR): a personal account of its pathogenesis and treatment. Proctor lecture.
    Machemer R
    Invest Ophthalmol Vis Sci; 1988 Dec; 29(12):1771-83. PubMed ID: 3056866
    [No Abstract]   [Full Text] [Related]  

  • 11. Ganciclovir implant.
    Charles NC
    Ophthalmology; 2006 May; 113(5):888. PubMed ID: 16650692
    [No Abstract]   [Full Text] [Related]  

  • 12. [Indications of vitrectomy in the treatment of rhegmatogenous detachment of the retina].
    Bonnet M
    Ophtalmologie; 1987; 1(1):95-100. PubMed ID: 3153831
    [No Abstract]   [Full Text] [Related]  

  • 13. Mild type acute retinal necrosis syndrome involving both eyes at three-year interval.
    Matsuo T; Nakayama T; Koyama T; Matsuo N
    Jpn J Ophthalmol; 1987; 31(3):455-60. PubMed ID: 3430861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stationary reflexes of the fundus oculi as a manifestation of paravascular fibroplasia and vitreo-retinal adhesions].
    Vodovozov AM
    Oftalmol Zh; 1974; 29(8):589-92. PubMed ID: 4453395
    [No Abstract]   [Full Text] [Related]  

  • 15. Current and future prospects for the prevention of ocular fibrosis.
    Dahlmann AH; Mireskandari K; Cambrey AD; Bailly M; Khaw PT
    Ophthalmol Clin North Am; 2005 Dec; 18(4):539-59. PubMed ID: 16314218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Growth factors in ophthalmology].
    Malecaze F; Chollet P; Plouet J; Mathis A; Arne JL
    J Fr Ophtalmol; 1992; 15(11):621-32. PubMed ID: 1298777
    [No Abstract]   [Full Text] [Related]  

  • 17. [Retinal detachment caused by stage D proliferative vitreoretinopathy. Temporary tamponade with silicone oil].
    Trepsat C
    Ophtalmologie; 1987; 1(2):213-6. PubMed ID: 3153853
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnosis and management of ocular complications of sickle hemoglobinopathies: Part II.
    Cohen SB; Fletcher ME; Goldberg MF; Jednock NJ
    Ophthalmic Surg; 1986 Feb; 17(2):110-6 contd. PubMed ID: 3515268
    [No Abstract]   [Full Text] [Related]  

  • 19. Single exposures to antiproliferatives: long-term effects on ocular fibroblast wound-healing behavior.
    Occleston NL; Daniels JT; Tarnuzzer RW; Sethi KK; Alexander RA; Bhattacharya SS; Schultz GS; Khaw PT
    Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):1998-2007. PubMed ID: 9331263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vitreoretinal proliferation. II. Pathogenic hypotheses].
    Baudouin C; Gastaud P
    J Fr Ophtalmol; 1994; 17(12):800-11. PubMed ID: 7722243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.